Camilla Comin

Azienda Ospedaliero-Universitaria Careggi — Italy

Medicine · Health Sciences

29h-index2.9kcitations108works1.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Diagnosis and Treatment(22), Lung Cancer Treatments and Mutations(21), Medical Imaging and Pathology Studies(12), Lung Cancer Research Studies(11), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(10)

Publications108 total

A Challenging Diagnosis of Hemophagocytic Lymphohistiocytosis with Unusual Pulmonary Manifestations: A Case Report
The Open Respiratory Medicine Journal·2025Open Access
Detection of Functional Progression in Interstitial Lung Diseases with Preserved Lung Function.
2025
Interstitial lung abnormalities: an Italian multicenter retrospective observational study.
2025
Histopathological UIP as a Prognostic Biomarker in Fibrotic Interstitial Lung Diseases with Preserved Lung Function.
2025
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC
Frontiers in Oncology·2025Open Access
EGFR Mutation Detection in Whole Slide Images of Non‐Small Cell Lung Cancers Using a Two‐Stage Deep Transfer Learning Approach
Cancer Medicine·2025Open Access
Circulating Tumor Cell-Free DNA as Prognostic Biomarker in Non-Small Cell Lung Cancer Patients Undergoing Immunotherapy: The CORELAB Experience
International Journal of Molecular Sciences·2025· 3 citedOpen Access
IPF and lung cancer. Retrospective analysis of antifibrotic drugs and thoracic surgery.
2024· 1 cited
Defining the clinical-radiological and anatomopathological phenotypes of persistent COVID in immunocompromised patients
2024
Radiological and histopathological features of Early Idiopathic Pulmunary Fibrosis (Early IPF)
2024
Large cell carcinoma of the lung: LDCT features and survival in screen-detected cases
European Journal of Radiology·2024· 1 citedOpen Access
Genetic signatures of <i>ERCC1</i> and <i>ERCC2</i> expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics·2024· 1 citedOpen Access
Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium
Frontiers in Medicine·2024· 9 citedOpen Access
ERCC1 and ERCC2 genes expression and their SNPs variants identify a favorable signature for SCLC patients treated with platinum-based chemotherapy
Research Square (Research Square)·2023Open Access
Successful Use of Monoclonal and Antiviral Therapy in Immunocompromised Patients With Persistent and/or Relapsing COVID-19
2023
The ThinICE protocol: the combination of cryobiopsy and ultraThin bronchoscopy for the peripheral lung nodule.
2023
Successful Use of Monoclonal and Antiviral Therapy in Immunocompromised Patients With Persistent and/or Relapsing COVID-19
2023· 1 cited
KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma
Cancers·2023· 3 citedOpen Access
A case report of a lung cancer patient with two uncommon EGFR mutations and a review of the literature: two sides of the same coin
Anti-Cancer Drugs·2023· 1 cited
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population
Frontiers in Oncology·2022· 7 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Luca Messerini(11), Luca Novelli(8), Andrea Lopes Pegna(6), Euǵenio Paci(5), Alessandro Gonfiotti(5), Cristina Maddau(5), Francesca Mazzoni(5), A Janní(5), Adele Caldarella(5), Fabio Cianchi(5), Giulia Picozzi(4), Mario Mascalchi(4), Laura Carrozzi(4), Fabio Falaschi(4), Michela Grazzini(4), Silvia Baiguera(4), Paolo Macchiarini(4), Luca Voltolini(4), F. Innocenti(3), Massimo Osvaldo Jaus(3)